Dermatologist Thomas Jennings, M.D., Ph.D., Joins UAMS

By Susan Van Dusen

He sees patients in the UAMS Winthrop P. Rockefeller Cancer Institute’s Dermatology Cancer Clinic, which offers a full range of treatments for early melanoma, basal cell carcinoma and squamous cell carcinoma and other skin cancers.

Mohs micrographic surgery is an outpatient procedure that is a precise way to remove tumors and minimize damage to the surrounding tissue. The procedure has one of the lowest recurrence rates among skin cancer removal techniques.

Jennings also is an assistant professor in the UAMS College of Medicine’s Department of Dermatology where he is director of dermatologic surgery.

He earned both his medical degree and a doctorate of philosophy in biochemistry and molecular biology at UAMS. He graduated summa cum laude with a bachelor’s degree in chemistry from Hendrix College.

After finishing an internship in internal medicine and a residency in dermatology at UAMS, Jennings completed a fellowship in procedural dermatology at the University of Alabama at Birmingham. He is certified by the American Board of Dermatology.

UAMS is the state’s only health sciences university, with colleges of Medicine, Nursing, Pharmacy, Health Professions and Public Health; a graduate school; hospital; northwest Arkansas regional campus; statewide network of regional centers; and six institutes: the Winthrop P. Rockefeller Cancer Institute, Jackson T. Stephens Spine & Neurosciences Institute, Harvey & Bernice Jones Eye Institute, Psychiatric Research Institute, Donald W. Reynolds Institute on Aging and Translational Research Institute. It is the only adult Level 1 trauma center in the state. UAMS has 2,727 students, 822 medical residents and five dental residents. It is the state’s largest public employer with more than 10,000 employees, including 1,200 physicians who provide care to patients at UAMS, its regional campuses throughout the state, Arkansas Children’s Hospital, the VA Medical Center and Baptist Health. Visit or Find us on FacebookTwitterYouTube or Instagram.